(redirected from central nervous system)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.

Continuous net settlement (CNS)

Method of securities clearing and settlement using a clearing house, which matches transactions to securities available, resulting in one net receive or deliver position at the end of the day.

Continuous Net Settlement

A clearing practice in which all buy and sell orders are settled within a brokerage firm. That is, all buy and sell orders are offset against each other on a particular trading day, such that only orders that are "left over" remain to be settled. This results in fewer securities needing to be moved into or out of a particular brokerage.


References in periodicals archive ?
Figure 40: Endpoints- Clinical Trials in Central Nervous System Disorders, Epilepsy, Completed Phase III Clinical Trials Classified Based on Other Secondary Endpoints, Global, 2000-2010 98
The prevalence of central nervous system (CNS) disorders in the European population, which represents a significant component of overall healthcare expenses, is exhibiting a steady rise.
This innovative strategy for getting drugs into the brain could open the door to a host of new treatments for pain, as well as for other conditions that involve the central nervous system," the Harvard authors said in the March 1993 edition.
Cells transplanted were Schwann cells; these make myelin in the peripheral nervous system but are not normally found in the central nervous system.
Roberts was responsible for drug discovery chemistry done in all the therapeutic areas represented at the corporate headquarters, which included diseases of the central nervous system as well as the vascular and metabolic therapeutic areas.
Focusing on psychiatry and neurology, Lundbeck USA is a specialty pharmaceutical company committed to advancing Central Nervous System care in the United States by bringing advanced products and information to the medical community, especially psychiatrists and neurologists, and patients and caregivers.
He adds that his team's microglial cell culture may help test drugs targeted at halting HIV infection in the central nervous system.
ACADIA is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders.
The failure of neurons to engage in further cell division after reaching maturity severely limits the body's ability to recover from damage to the central nervous system.
headquartered in Los Angeles, CA, is a privately held biopharmaceutical company developing products for the treatment acute and chronic disorders of the central nervous system based on proprietary technology for modulating the interaction between the nervous and the immune systems.
This, in turn, short-circuits electrical messages sent from the central nervous system to the rest of the body.

Full browser ?